BioSante Pharmaceuticals, Inc. (BPAX)

[Just the facts maam]

Rgshredder, good questions.

1.If getting libi was Simes' goal, why take an exit with this merger? As a Research Scientist in a past life, I find it's not a simple thing to let go of a project that you've spent a large part of your career studying...It seems in this deal, he's basically walking away. Could it be that the board didn't like his management of things thus far and decided to have a change in leadership?

As a research scientist, if you knew the best way to get your project to succeed was to hand it over to someone who could take it the rest of the way, would you continue trying and risk having it not succeed? Coaches hand off their proteges to better coaches if they have the interest of the protege at heart. I am not saying this what happened, but a good CEO would realize this.

2.With that said, if layoffs are occurring (or will occur if merger goes through) to what purpose does this serve in regards to continuing libigel? I would think dismissing those involved in the r/d up to date and handing the reigns over to ANIP is going to slow development; in the same breath, ANIP is not R/D they're manufacturing...which, as nutsy pointed out, should speak volumes as to where they are at with Libigel and if this is indeed the case, why all the bloody silence about it...

If Abbvie is involved the have capable R&D teams and have had people involved in the development of Libigel. I believe they will somehow be involved in this deal, and will have secured employment for those Biosante employees needed to move Libigel to market.

3 .All the actions of Tang over the course of this year still warrant investigation because at this point, I think they're in the same position all of us are...or could it be they took the position they did to influence/hasten this merger?

It would be interesting to see if Tang has a stake in ANI. Knowing this could help answer this question.